¼¼°èÀÇ ¼öÁ¤Ã¼À¯È­ ±â±â ½ÃÀå
Phacoemulsification Devices
»óǰÄÚµå : 1794621
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 278 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,215,000
PDF & Excel (Single User License) help
PDF & Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÆÄÀÏ ³» ÅØ½ºÆ®ÀÇ º¹»ç ¹× ºÙ¿©³Ö±â´Â °¡´ÉÇÏÁö¸¸, Ç¥/±×·¡ÇÁ µîÀº º¹»çÇÒ ¼ö ¾ø½À´Ï´Ù. Àμâ´Â 1ȸ °¡´ÉÇϸç, Àμ⹰ÀÇ ÀÌ¿ë¹üÀ§´Â ÆÄÀÏ ÀÌ¿ë¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,647,000
PDF & Excel (Global License to Company and its Fully-owned Subsidiaries) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ¹× 100% ÀÚȸ»çÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÏ½Ç ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â 1Àδç 1ȸ °¡´ÉÇϸç, Àμ⹰ÀÇ ÀÌ¿ë¹üÀ§´Â ÆÄÀÏ ÀÌ¿ë¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼öÁ¤Ã¼À¯È­ ±â±â ¼¼°è ½ÃÀåÀº 2030³â±îÁö 27¾ï ´Þ·¯¿¡ ´ÞÇÒ Àü¸Á

2024³â¿¡ 21¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ¼öÁ¤Ã¼À¯È­ ±â±â ¼¼°è ½ÃÀåÀº ºÐ¼® ±â°£ÀÎ 2024-2030³â¿¡ CAGR 4.3%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 27¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ ¼öÁ¤Ã¼À¯È­¼ú¿ë ¼Ò¸ðǰÀº CAGR 5.1%¸¦ ±â·ÏÇÏ¸ç ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 18¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¼öÁ¤Ã¼À¯È­¼ú¿ë ½Ã½ºÅÛ ºÐ¾ßÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ µ¿¾È CAGR 2.8%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 5¾ï 8,170¸¸ ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 8.0%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ¼öÁ¤Ã¼À¯È­ ±â±â ½ÃÀåÀº 2024³â¿¡ 5¾ï 8,170¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦ ´ë±¹ÀÎ Áß±¹Àº 2024³âºÎÅÍ 2030³â±îÁö CAGR 8.0%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 5¾ï 6,840¸¸ ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖ°í, ºÐ¼® ±â°£ µ¿¾È CAGRÀº °¢°¢ 1.7%¿Í 3.4%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 2.5%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ ¼öÁ¤Ã¼À¯È­ ±â±â ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

Àü ¼¼°èÀûÀ¸·Î ¼öÁ¤Ã¼À¯È­ ±â±â¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÏ´Â ÀÌÀ¯´Â ¹«¾ùÀϱî?

ƯÈ÷ °í·ÉÈ­ »çȸÀÇ ¹é³»Àå À¯º´·ü Áõ°¡·Î ÀÎÇØ ¼öÁ¤Ã¼À¯È­ ±â±â¿¡ ´ëÇÑ ¼¼°è ¼ö¿ä°¡ ²ÙÁØÈ÷ ±ÞÁõÇϰí ÀÖ½À´Ï´Ù. ¹é³»ÀåÀº Àü ¼¼°èÀûÀ¸·Î ½Ã°¢Àå¾Ö¿Í ½Ç¸íÀÇ ÁÖ¿ä ¿øÀÎ Áß ÇϳªÀ̸ç, ¹é³»Àå ¼ö¼úÀº ÃÖ¼Òħ½ÀÀûÀ̰í ȸº¹ÀÌ ºü¸£¸ç ¼º°ø·üÀÌ ³ôÀº ¼öÁ¤Ã¼À¯È­¼úÀÌ °ñµå ½ºÅÄ´Ùµå·Î ÀÚ¸® Àâ°í ÀÖ½À´Ï´Ù. ƯÈ÷ ºÏ¹Ì, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç ÀϺΠÁö¿ª¿¡¼­´Â ³ëÀÎ Àα¸°¡ Áõ°¡ÇÔ¿¡ µû¶ó È¿À²ÀûÀÌ°í ¾ÈÀüÇÏ¸ç ½Å·ÚÇÒ ¼ö ÀÖ´Â ¹é³»Àå Ä¡·áÀÇ Çʿ伺ÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. Á¤ºÎ¿Í ÀÇ·á ½Ã½ºÅÛÀº ƯÈ÷ ¿¹¹æ °¡´ÉÇÑ ½Ç¸íÀ» ÁÙÀÌ´Â °ÍÀÌ °øÁß º¸°ÇÀÇ Àǹ«ÀÎ ±¹°¡¿¡¼­ Áõ°¡Çϴ ȯÀÚ ºÎ´ãÀ» °ü¸®Çϱâ À§ÇØ ¾È°ú ÀÇ·á ÀÎÇÁ¶ó¿¡ ¸¹Àº ÅõÀÚ¸¦ Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ȯÀÚµéÀÇ ÀνÄÀÌ ³ô¾ÆÁ® ´õ ³ªÀº ¼ö¼ú °á°ú¸¦ ¾ò±â ½¬¿öÁø °ÍÀÌ ±âÁ¸ÀÇ ³¶¿Ü ¹é³»Àå ÀýÁ¦¼úº¸´Ù ¼öÁ¤Ã¼À¯È­¼úÀÌ ºü¸£°Ô º¸±ÞµÇ´Â µ¥ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ÃֽмöÁ¤Ã¼À¯È­ ½Ã½ºÅÛÀÌ Á¦°øÇÏ´Â Æí¸®ÇÔ°ú Á¤È®¼ºÀº ½ÅÈï ½ÃÀåÀÇ °¡Ã³ºÐ ¼Òµæ Áõ°¡ ¹× ÀÇ·á º¸ÇèÀÇ °¡¿ë¼º Çâ»ó°ú ÇÔ²² ÀÌ·¯ÇÑ Ã·´Ü ±â±âÀÇ º¸±ÞÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀÚ¼± »ç¾÷°ú NGO ÁÖµµÀÇ ÀÌ´Ï¼ÅÆ¼ºê´Â ¼öÁ¤Ã¼À¯È­¼ú ±â¼úÀ» ¼Ò¿ÜµÈ Áö¿ª¿¡ µµÀÔÇÏ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖÀ¸¸ç, ½ÃÀå Àúº¯À» È®´ëÇÏ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½Ã·Â °Ç°­¿¡ ´ëÇÑ °ü½ÉÀÇ Áõ°¡´Â Àü ¼¼°èÀûÀ¸·Î »îÀÇ Áú°ú ±â´ÉÀû ¼ö¸í¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼­ ´õ¿í °¡¼ÓÈ­µÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

±â¼úÀÇ ¹ßÀüÀÌ ¾È°ú ¼ö¼úÀÇ Á¤È®¼ºÀ» ¾î¶»°Ô ÀçÁ¤ÀÇÇϰí Àִ°¡?

¼öÁ¤Ã¼À¯È­ ±â±âÀÇ ±â¼ú Çõ½ÅÀº ¼ö¼úÀÇ Á¤È®¼º, ¾ÈÀü¼º, ȯÀÚ °á°ú¸¦ ȹ±âÀûÀ¸·Î °³¼±Çϰí ÀÖ½À´Ï´Ù. Ãֽбâ±â¿¡´Â ÷´Ü À¯Ã¼ ½Ã½ºÅÛ, ¼ö¼ú Áß ½Ç½Ã°£ Çǵå¹é, ¿­ ¼Õ»óÀ» ÃÖ¼ÒÈ­ÇÏ°í ¼öÁ¤Ã¼ Á¦°Å È¿À²À» Çâ»ó½ÃŰ´Â ¿¡³ÊÁö Á¶Àý ±â´ÉÀÌ Å¾ÀçµÇ¾î ÀÖ½À´Ï´Ù. ¹Ì¼¼ Àý°³ ¹é³»Àå ¼ö¼ú(MICS)·ÎÀÇ ÀüȯÀº ¼ö¼úÀÇ ÅëÁ¦·ÂÀ» ¶³¾î¶ß¸®Áö ¾ÊÀ¸¸é¼­ ´õ ÀÛÀº Àý°³¸¦ ¿ëÀÌÇÏ°Ô ÇÏ´Â ´õ ÀÛ°í Á¤±³ÇÑ ÇÚµåÇǽº¿Í ±â°è¿¡ ´ëÇÑ ¼ö¿ä¸¦ âÃâÇϰí ÀÖ½À´Ï´Ù. ºñƲ¸² ÃÊÀ½ÆÄ ±â¼ú, Áö´ÉÇü ÈíÀÔ Á¦¾î, ÅëÇÕÇü ±¤°£¼· ´ÜÃþÃÔ¿µ±â(OCT) µîÀÇ ±â¼ú Çõ½ÅÀº ¹é³»Àå ¼ö¼ú ¹æ¹ýÀ» ¿ÏÀüÈ÷ ¹Ù²Ù¾î ³õ¾Ò½À´Ï´Ù. ÇöÀç ¸¹Àº ½Ã½ºÅÛÀÌ ·»ÁîÀÇ °æµµ, ȯÀÚÀÇ ´«ÀÇ ÇØºÎÇÐÀû ±¸Á¶ ¹× ¿Ü°ú ÀÇ»çÀÇ ¼±È£µµ¿¡ µû¶ó ¸ÂÃãÇü ¼³Á¤À» Á¦°øÇÏ¿© ÇÕº´Áõ °¨¼Ò¿Í ÇÔ²² ÃÖÀûÈ­µÈ °á°ú¸¦ Á¦°øÇÕ´Ï´Ù. ÅÍÄ¡½ºÅ©¸° ÀÎÅÍÆäÀ̽º¿Í Ŭ¶ó¿ìµå ¿¬°áÀÇ ÅëÇÕÀ¸·Î ½Ç½Ã°£ µ¥ÀÌÅÍ ÃßÀû ¹× ¼ö¼ú °á°ú ºÐ¼®ÀÌ °¡´ÉÇÏ¿©, ½Ã¼ú ±³À° ¹× Ç¥ÁØÈ­°¡ ¸ðµÎ °­È­µÇ¾ú½À´Ï´Ù. ¶ÇÇÑ, ÆèÅä¼¼ÄÁµå ·¹ÀÌÀú º¸Á¶ ¹é³»Àå ¼ö¼ú(FLACS)ÀÇ µîÀåÀº ¼öÁ¤Ã¼ ÆÄ¼â¿Í ÇǸ· Àý°³ Á¤È®µµ¸¦ Çâ»ó½ÃÄÑ À¯È­ÈíÀÔ¼úÀ» º¸¿ÏÇϰí ÀÖ½À´Ï´Ù. ¾÷°è ±â¾÷µéÀº ½Ã½ºÅÛÀÇ ÀÎü°øÇÐÀû, ¿¡³ÊÁö È¿À², ¹ÝÀÀ¼ºÀ» ³ôÀ̱â À§ÇØ ¿¬±¸°³¹ß¿¡ ¸¹Àº ÅõÀÚ¸¦ Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼ú Çõ½ÅÀº ÀÓ»ó °á°ú¸¦ °³¼±ÇÒ »Ó¸¸ ¾Æ´Ï¶ó, ´õ ¸¹Àº ¿Ü°úÀÇ»ç Áý´Ü¿¡°Ô ±â±âÀÇ »ç¿ë ÆíÀǼºÀ» È®´ëÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¾ß°¡ °è¼Ó ¹ßÀüÇÔ¿¡ µû¶ó ÷´Ü ¼öÁ¤Ã¼À¯È­ ½Ã½ºÅÛÀº ´õ¿í Áö´ÉÀûÀÌ°í ´ú ħ½ÀÀûÀÌ¸ç °³º° ¼ö¼úÀÇ ¿ä±¸¿¡ ¸Â°Ô Á¶Á¤µÉ °ÍÀÔ´Ï´Ù.

ÀÇ·á ÀÎÇÁ¶ó¿Í ¼ö¼ú ±³À°ÀÌ ½ÃÀå ħÅõ¿¡ ¾î¶² ¿ªÇÒÀ» Çϴ°¡?

¼öÁ¤Ã¼À¯È­ ±â±âÀÇ º¸±Þ°ú äÅÃÀº ¼÷·ÃµÈ ¾È°ú ÀÇ»çÀÇ À¯¹«¿Í ÀÇ·á ÀÎÇÁ¶óÀÇ Ãæ½Çµµ¿¡ µû¶ó Å©°Ô ¿µÇâÀ» ¹Þ½À´Ï´Ù. ÃÖ÷´Ü ¼ö¼ú ±â±â¿¡ ´ëÇÑ Á¢±Ù¼ºÀÌ ³ôÀº °í¼Òµæ ±¹°¡¿¡¼­´Â ¹é³»Àå Á¦°Å¼úÀÌ ¼öÁ¤Ã¼À¯È­¼ú·Î °ÅÀÇ ¿ÏÀüÈ÷ ´ëüµÇ°í ÀÖ½À´Ï´Ù. ±×·¯³ª ¸¹Àº ÁßÀú¼Òµæ ±¹°¡¿¡¼­´Â ¼÷·ÃµÈ ¿Ü°úÀÇ»ç ºÎÁ·°ú ¼ö¼ú ¼¾ÅÍ ½Ã¼³ ºÎÁ·À¸·Î ÀÎÇØ ¼öÁ¤Ã¼À¯È­ ±â±â¸¦ º»°ÝÀûÀ¸·Î µµÀÔÇÏ´Â µ¥ ¿©ÀüÈ÷ ÇѰ谡 ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ °ÝÂ÷¸¦ ÇØ¼ÒÇϱâ À§ÇØ ¿©·¯ Á¦Á¶¾÷ü¿Í ºñ¿µ¸® ´Üü°¡ Àü ¼¼°è ¾Æ¿ô¸®Ä¡ ÇÁ·Î±×·¥À» ÅëÇØ ±³À° ¹× ±â¼ú Çâ»ó ³ë·Â¿¡ ÈûÀ» ½ñ°í ÀÖ½À´Ï´Ù. ü°èÀûÀÎ ±³À° ¸ðµâ, °¡»óÇö½Ç ½Ã¹Ä·¹ÀÌÅÍ, ¶óÀÌºê ¼ö¼ú ¿öÅ©¼¥Àº »õ·Î¿î ¼¼´ëÀÇ ¾È°ú ÀÇ»çµéÀÌ ¼öÁ¤Ã¼À¯È­¼ú ±â¼úÀ» ½ÀµæÇÏ´Â µ¥ µµ¿òÀÌ µÇ°í ÀÖ½À´Ï´Ù. µ¿½Ã¿¡ ½ÅÈï±¹¿¡¼­´Â ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ¿Í ¹Î°£ ¾È°ú º´¿øÀÇ ±ÞÁõÀ¸·Î ÀÎÇØ °íǰÁúÀÇ ºñ¿ë È¿À²ÀûÀÎ ¼ö¼ú ½Ã½ºÅÛ¿¡ ´ëÇÑ »õ·Î¿î ¼ö¿ä°¡ ¹ß»ýÇϰí ÀÖ½À´Ï´Ù. ¹é³»Àå ¼ö¼úÀ» Æ÷ÇÔÇÑ º¸Çè Àû¿ë ¹× Á¤ºÎ Áö¿ø ÀÇ·á ÇÁ·Î±×·¥µµ ȯÀÚ ¼ö¸¦ Áõ°¡½ÃÄÑ ÀÇ·á±â°üÀÌ ¼öÁ¤Ã¼À¯È­ ½Ã½ºÅÛ¿¡ ´ëÇÑ ÅõÀÚ¸¦ À¯µµÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¼ö¼ú ÇÁ·ÎÅäÄݰú ÀÎÁõ ¿ä°ÇÀÇ Ç¥ÁØÈ­·Î ÀÎÇØ ±¹Á¦ÀûÀÎ Ä¡·á ±âÁØÀ» ÃæÁ·Çϱâ À§ÇØ Ã·´Ü ±â±â¸¦ µµÀÔÇÏ´Â º´¿øÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. Àü ¼¼°èÀûÀ¸·Î ¹é³»ÀåÀ¸·Î ÀÎÇÑ ½Ç¸í·üÀÌ Áõ°¡Çϰí ÀÖ´Â °¡¿îµ¥, ÀÌ·¯ÇÑ ±â¼úÀ» ³Î¸® º¸±ÞÇϱâ À§Çؼ­´Â ¼ö¼ú ´É·Â°ú ÀÓ»óÀÇÀÇ Àü¹® Áö½ÄÀÇ È®´ë°¡ ÇʼöÀûÀÔ´Ï´Ù. ÀÇ·á ¼­ºñ½º Á¦°ø°ú ±â¼ú °³¹ß¿¡ ´ëÇÑ ÁýÁßÀûÀÎ ÅõÀÚ·Î ÀÎÇØ ¸¹Àº ¹Ì°³Ã´ ½ÃÀåÀÌ ºü¸£°Ô ¼ºÀåÇÒ ¼ö ÀÖ´Â ¿©°ÇÀÌ Á¶¼ºµÇ°í ÀÖ½À´Ï´Ù.

¼öÁ¤Ã¼À¯È­ ±â±â ½ÃÀåÀ» À̲ô´Â ÁÖ¿ä ¼ºÀå ÃËÁø¿äÀÎÀº ¹«¾ùÀΰ¡?

¼öÁ¤Ã¼À¯È­ ±â±â ½ÃÀåÀÇ ¼ºÀåÀº ±â¼ú ¹ßÀü, Àα¸Åë°èÇÐÀû º¯È­, ÀÇ·á ¼­ºñ½º Á¦°ø ¸ðµ¨ÀÇ ÁøÈ­¿Í °ü·ÃµÈ ¸î °¡Áö ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ÁÖ¿ä ¿äÀÎÀ¸·Î´Â ¼¼°è Àα¸ÀÇ ±Þ¼ÓÇÑ °í·ÉÈ­¸¦ µé ¼ö ÀÖÀ¸¸ç, ÀÌ¿¡ µû¶ó ³ëÈ­¿¡ µû¸¥ ¹é³»Àå ¹ßº´·üÀÌ ³ô¾ÆÁö°í, ÀÌ¿¡ µû¶ó ¼ö¼úÀÇ Çʿ伺ÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ¿Í ÇÔ²² °³¼±µÈ À¯Ã¼¿ªÇÐ, ½Ç½Ã°£ ¼ö¼ú ºÐ¼®, ÀûÀÀ¼º ³ôÀº ¿¡³ÊÁö °ø±Þ ½Ã½ºÅÛ µî ±â±â ±â´ÉÀÇ Áö¼ÓÀûÀÎ ¹ßÀüÀ¸·Î ¼ö¼ú °á°ú¿Í ȯÀÚ ¾ÈÀüÀÌ Å©°Ô Çâ»óµÇ¾ú½À´Ï´Ù. ÃÖ¼Òħ½ÀÀû ½Ã¼ú°ú Á¤¹Ð ±â±â¿¡ ´ëÇÑ ¿Ü°ú ÀÇ»çµéÀÇ ¼±È£µµ°¡ ³ô¾ÆÁö¸é¼­ ¼öÁ¤Ã¼À¯È­¼úÀÌ ¹é³»Àå Á¦°Å¼úÀÇ ¹Ù¶÷Á÷ÇÑ ¹æ¹ýÀ¸·Î ´õ¿í È®°íÈ÷ ÀÚ¸® Àâ°í ÀÖ½À´Ï´Ù. ÀÇ·á ¼­ºñ½º Á¦°ø Ãø¸é¿¡¼­´Â °³ÀÎ ¾È°ú Ŭ¸®´Ð, ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ, ¾È°ú Àü¹® ³×Æ®¿öÅ©ÀÇ È®´ë·Î ÀÎÇØ ¼ÒÇü, È޴뼺, È®À强ÀÌ ¶Ù¾î³­ ¼ö¼ú ½Ã½ºÅÛ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¼ÒºñÀÚ Çൿµµ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖÀ¸¸ç, ȯÀÚµéÀº Á¡Á¡ ´õ ºü¸¥ ȸº¹, °íÈ­Áú ½Ã°¢Àû °á°ú, ·¹ÀÌÀú Áö¿øÀ» ÅëÇÑ ¸ÂÃãÈ­¸¦ ¿ä±¸Çϰí ÀÖ½À´Ï´Ù. Àεµ³ª Áß±¹ °°Àº ³ª¶ó¿¡¼­´Â Á¤ºÎ¿¡¼­ ÀÚ±ÝÀ» Áö¿øÇÏ´Â ¹é³»Àå ÅðÄ¡ ÇÁ·Î±×·¥ÀÌ ÀÖ°í, À¯·´°ú ¹Ì±¹¿¡¼­´Â ü°èÈ­µÈ »óȯ ü°è°¡ Àֱ⠶§¹®¿¡ ÀÌ·¯ÇÑ ¼±ÁøÀûÀÎ ½Ã½ºÅÛ¿¡ ÀçÁ¤Àû ½ÇÇà °¡´É¼º°ú Á¢±Ù¼ºÀ» °¡Á®´Ù ÁÝ´Ï´Ù. ¶ÇÇÑ, ¼±ÅÃÀû ¹é³»Àå ¼ö¼úÀÇ Áõ°¡¿Í 2Â÷ ÀÇ·á¼¾ÅÍ ¹× ³óÃÌ Áö¿ª ÀÇ·á¼¾ÅÍ·ÎÀÇ ¹é³»Àå ¼ö¼ú È®´ë´Â ±â±â Á¦Á¶¾÷ü¿¡°Ô »õ·Î¿î ±æÀ» ¿­¾îÁÖ°í ÀÖ½À´Ï´Ù. ¸¶Áö¸·À¸·Î, Àü ¼¼°èÀûÀ¸·Î ¼ö¼ú ±³À° ¹× ±â±â ±ÔÁ¦ÀÇ Á¶È­·Î ÀÎÇØ ½Å±â¼úÀÇ ½ÃÀå Ãâ½Ã ½Ã°£ÀÌ ´ÜÃàµÇ°í, °æÀï·Â ÀÖ´Â ±â¼ú Çõ½ÅÀÌ ÃËÁøµÇ°í, Áö¿ª °£ ´õ ³ÐÀº ¹üÀ§ÀÇ Á¦Ç°À» »ç¿ëÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù.

ºÎ¹®

Á¦Ç°(¼öÁ¤Ã¼À¯È­¼ú¿ë ¼Ò¸ðǰ, ¼öÁ¤Ã¼À¯È­¼ú¿ë ½Ã½ºÅÛ), ÃÖÁ¾»ç¿ëÀÚ(º´¿ø ÃÖÁ¾»ç¿ëÀÚ, Ŭ¸®´Ð ÃÖÁ¾»ç¿ëÀÚ, Á¶»ç±â°ü ÃÖÁ¾»ç¿ëÀÚ)

Á¶»ç ´ë»ó ±â¾÷ »ç·Ê

AI ÅëÇÕ

Global Industry Analysts´Â °ËÁõµÈ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AI ÅøÀ» ÅëÇØ ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ Çõ½ÅÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â ÀϹÝÀûÀÎ LLM ¹× ¾÷°èº° SLM Äõ¸®¸¦ µû¸£´Â ´ë½Å ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ¹æ´ëÇÑ ¾çÀÇ ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»ç ¼ÒÀçÁö, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±âÁØÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¸ÅÃâ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº Ç϶ô, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû, °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

KSM
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Phacoemulsification Devices Market to Reach US$2.7 Billion by 2030

The global market for Phacoemulsification Devices estimated at US$2.1 Billion in the year 2024, is expected to reach US$2.7 Billion by 2030, growing at a CAGR of 4.3% over the analysis period 2024-2030. Phacoemulsification Consumables, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$1.8 Billion by the end of the analysis period. Growth in the Phacoemulsification Systems segment is estimated at 2.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$581.7 Million While China is Forecast to Grow at 8.0% CAGR

The Phacoemulsification Devices market in the U.S. is estimated at US$581.7 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$568.4 Million by the year 2030 trailing a CAGR of 8.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.7% and 3.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.5% CAGR.

Global Phacoemulsification Devices Market - Key Trends & Drivers Summarized

Why Is the Demand for Phacoemulsification Devices Rising Across the Globe?

The global demand for phacoemulsification devices is witnessing a steady surge due to the rising prevalence of cataracts, particularly among the aging population. Cataracts remain one of the leading causes of visual impairment and blindness globally, and phacoemulsification has become the gold standard in cataract surgery due to its minimally invasive nature, faster recovery time, and high success rate. The increasing geriatric demographic, especially in regions like North America, Europe, and parts of Asia-Pacific, has driven the need for efficient, safe, and reliable cataract treatment options. Governments and healthcare systems are investing significantly in ophthalmic care infrastructure to manage the growing patient burden, particularly in countries with public health mandates to reduce preventable blindness. Moreover, increased patient awareness and the accessibility of better surgical outcomes are contributing to the rapid adoption of phacoemulsification over traditional extracapsular cataract extraction methods. The convenience and precision offered by modern phacoemulsification systems, combined with rising disposable incomes and greater availability of health insurance in emerging markets, have further encouraged the uptake of these advanced devices. Additionally, philanthropic and NGO-led initiatives are playing a significant role in bringing phacoemulsification technologies to underserved areas, broadening the market reach. This increased focus on visual health is expected to accelerate further with continued global emphasis on quality of life and functional longevity.

How Are Technological Advancements Redefining Surgical Precision in Ophthalmology?

Technological innovations in phacoemulsification devices are dramatically improving surgical precision, safety, and patient outcomes. Modern devices now come equipped with advanced fluidics systems, real-time intraoperative feedback, and enhanced energy modulation capabilities that minimize thermal damage and improve lens removal efficiency. The shift toward microincision cataract surgery (MICS) has created a demand for more compact and sophisticated handpieces and machines that facilitate smaller incisions without compromising surgical control. Innovations such as torsional ultrasound technology, intelligent aspiration control, and integrated optical coherence tomography (OCT) have transformed how cataract surgeries are performed. Many systems now offer customizable settings based on lens hardness, patient eye anatomy, and surgeon preferences, resulting in optimized outcomes with reduced complications. Integration of touchscreen interfaces and cloud connectivity allows real-time data tracking and surgical performance analysis, which enhances both procedural training and standardization. Furthermore, the rise of femtosecond laser-assisted cataract surgery (FLACS) is complementing phacoemulsification procedures by improving lens fragmentation and capsulotomy precision. Industry players are investing heavily in R&D to make systems more ergonomic, energy-efficient, and responsive. Such innovations not only boost clinical outcomes but also expand the usability of devices to newer surgeon cohorts. As the field continues to evolve, high-tech phacoemulsification systems are poised to become even more intelligent, less invasive, and tailored to individual surgical needs.

What Role Do Healthcare Infrastructure and Surgical Training Play in Market Penetration?

The spread and adoption of phacoemulsification devices are heavily influenced by the availability of skilled ophthalmic surgeons and the robustness of healthcare infrastructure. In high-income countries, where access to state-of-the-art surgical facilities is more common, phacoemulsification has almost entirely replaced older cataract extraction techniques. However, in many low- and middle-income nations, the lack of trained surgeons and under-equipped surgical centers continues to limit the full-scale adoption of phacoemulsification devices. To bridge this gap, several manufacturers and non-profit organizations are focusing on education and skill-building initiatives through global outreach programs. Structured training modules, virtual reality simulators, and live surgical workshops are helping to train a new generation of ophthalmologists in phacoemulsification techniques. At the same time, the proliferation of ambulatory surgical centers and private eye hospitals in emerging economies is creating new demand for high-quality, cost-effective surgical systems. Insurance coverage and government-sponsored health programs that include cataract surgery have also boosted patient volumes, prompting institutions to invest in phacoemulsification systems. Moreover, standardization of surgical protocols and accreditation requirements is encouraging more hospitals to adopt advanced equipment to meet international care benchmarks. As the global burden of cataract-related blindness grows, expanding surgical capacity and clinician expertise will be essential to enabling widespread adoption of these technologies. With targeted investment in healthcare delivery and skills development, many underpenetrated markets are poised for accelerated growth.

What Are the Key Growth Drivers Powering the Phacoemulsification Devices Market?

The growth in the phacoemulsification devices market is driven by several factors related to technological sophistication, changing demographics, and evolving healthcare delivery models. A primary driver is the rapid aging of the global population, which is leading to a higher incidence of age-related cataracts and consequently, a greater need for surgical intervention. In parallel, the continuous advancement of device functionality such as improved fluidics, real-time surgical analytics, and adaptive energy delivery systems has significantly elevated surgical outcomes and patient safety. Increasing surgeon preference for minimally invasive techniques and precision tools has further solidified phacoemulsification as the preferred method of cataract removal. On the healthcare delivery side, the expansion of private eye clinics, outpatient surgical centers, and specialized ophthalmology networks has amplified the demand for compact, portable, and scalable surgical systems. Consumer behavior is also playing a critical role, with patients increasingly seeking faster recovery, high-definition visual outcomes, and laser-assisted customization. Government-funded cataract elimination programs in countries like India and China, as well as structured reimbursement frameworks in Western nations, have provided financial viability and accessibility to these advanced systems. Additionally, the growing volume of elective cataract procedures and the expansion of cataract surgery into secondary and rural healthcare centers are opening new avenues for device manufacturers. Lastly, the global harmonization of surgical training and device regulation is accelerating time-to-market for new technologies, fueling competitive innovation and broader product availability across regions.

SCOPE OF STUDY:

The report analyzes the Phacoemulsification Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Phacoemulsification Consumables, Phacoemulsification Systems); End-Use (Hospitals End-Use, Clinics End-Use, Research Institutes End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 44 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â